IL116225A - Process and intermediates for the selective preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives - Google Patents

Process and intermediates for the selective preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives

Info

Publication number
IL116225A
IL116225A IL11622595A IL11622595A IL116225A IL 116225 A IL116225 A IL 116225A IL 11622595 A IL11622595 A IL 11622595A IL 11622595 A IL11622595 A IL 11622595A IL 116225 A IL116225 A IL 116225A
Authority
IL
Israel
Prior art keywords
formula
enantiomerically pure
alkyl
esters
iiia
Prior art date
Application number
IL11622595A
Other languages
English (en)
Other versions
IL116225A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to IL13372095A priority Critical patent/IL133720A/xx
Publication of IL116225A0 publication Critical patent/IL116225A0/xx
Priority to IL13372099A priority patent/IL133720A0/xx
Publication of IL116225A publication Critical patent/IL116225A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL11622595A 1994-12-05 1995-12-01 Process and intermediates for the selective preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives IL116225A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL13372095A IL133720A (en) 1994-12-05 1995-12-01 Pyrrolidine compounds and process of preparing them
IL13372099A IL133720A0 (en) 1994-12-05 1999-12-24 Pyrrolidine compounds and process of preparing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4443168A DE4443168A1 (de) 1994-12-05 1994-12-05 Neues hochselektives Verfahren zur Herstellung von enantiomerenreinen phenylsubstituierten 1,4-Dihydropyridin-3,5-dicarbonsäurederivaten

Publications (2)

Publication Number Publication Date
IL116225A0 IL116225A0 (en) 1996-03-31
IL116225A true IL116225A (en) 2000-06-29

Family

ID=6534908

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11622595A IL116225A (en) 1994-12-05 1995-12-01 Process and intermediates for the selective preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives

Country Status (27)

Country Link
US (4) US5700948A (zh)
EP (2) EP0716081B1 (zh)
JP (1) JP3891500B2 (zh)
KR (1) KR100396011B1 (zh)
CN (5) CN1079793C (zh)
AT (1) ATE322482T1 (zh)
AU (1) AU702274B2 (zh)
CA (1) CA2164276C (zh)
CZ (1) CZ296438B6 (zh)
DE (2) DE4443168A1 (zh)
DK (1) DK0716081T3 (zh)
ES (1) ES2262138T3 (zh)
FI (1) FI115908B (zh)
HU (1) HU214683B (zh)
IL (1) IL116225A (zh)
MX (1) MX9504954A (zh)
MY (1) MY112938A (zh)
NO (1) NO312832B1 (zh)
NZ (1) NZ280578A (zh)
PL (1) PL183604B1 (zh)
PT (1) PT716081E (zh)
RU (1) RU2155752C2 (zh)
SG (1) SG73352A1 (zh)
SI (1) SI0716081T1 (zh)
SK (1) SK282428B6 (zh)
TW (1) TW310324B (zh)
ZA (1) ZA9510263B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102533154B1 (ko) 2022-09-22 2023-05-17 임태형 안전계단 난간대

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932646A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylate
JPS6058239B2 (ja) * 1978-07-20 1985-12-19 山之内製薬株式会社 新規セフアロスポリン誘導体
DE2911029C2 (de) * 1979-03-21 1985-03-14 Kombi-Lift Montage- Und Handelsgesellschaft Mbh, 5650 Solingen Vorrichtung zum Haltern der Führungsrollen für die Lastseile eines Fassadenseilaufzuges in einem oben am Gebäude fest angeordneten Gehäuse
GR850872B (zh) * 1984-04-16 1985-11-25 Yamanouchi Pharma Co Ltd
US4539302A (en) * 1984-04-30 1985-09-03 E. I. Du Pont De Nemours And Company Recovery of zerovalent nickel complexes
DE3423105A1 (de) * 1984-06-22 1986-01-02 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung optisch aktiver 1,4-dihydropyridine

Also Published As

Publication number Publication date
CA2164276C (en) 2007-04-10
CZ320595A3 (en) 1996-06-12
NO954885D0 (no) 1995-12-01
MX9504954A (es) 1997-01-31
ATE322482T1 (de) 2006-04-15
JP3891500B2 (ja) 2007-03-14
PL183604B1 (pl) 2002-06-28
CN1094926C (zh) 2002-11-27
CN1105102C (zh) 2003-04-09
CN1079793C (zh) 2002-02-27
HU214683B (hu) 1998-04-28
NO954885L (no) 1996-06-06
CZ296438B6 (cs) 2006-03-15
USRE36607E (en) 2000-03-07
CN1131664A (zh) 1996-09-25
JPH08225529A (ja) 1996-09-03
CN1094486C (zh) 2002-11-20
RU2155752C2 (ru) 2000-09-10
HUT74292A (en) 1996-11-28
CA2164276A1 (en) 1996-06-06
NO312832B1 (no) 2002-07-08
CN1269357A (zh) 2000-10-11
US5849924A (en) 1998-12-15
HU9503438D0 (en) 1996-01-29
CN1269362A (zh) 2000-10-11
IL116225A0 (en) 1996-03-31
AU3915095A (en) 1996-06-13
EP1443043A2 (de) 2004-08-04
SI0716081T1 (sl) 2006-06-30
FI955825A (fi) 1996-06-06
DK0716081T3 (da) 2006-08-07
KR960022463A (ko) 1996-07-18
SG73352A1 (en) 2000-06-20
KR100396011B1 (ko) 2003-11-10
FI115908B (fi) 2005-08-15
DE4443168A1 (de) 1996-06-13
ES2262138T3 (es) 2006-11-16
FI955825A0 (fi) 1995-12-04
EP0716081B1 (de) 2006-04-05
AU702274B2 (en) 1999-02-18
MY112938A (en) 2001-10-31
EP0716081A1 (de) 1996-06-12
SK152695A3 (en) 1996-06-05
CN1269359A (zh) 2000-10-11
US5700948A (en) 1997-12-23
CN1269358A (zh) 2000-10-11
ZA9510263B (en) 1996-06-12
SK282428B6 (sk) 2002-01-07
NZ280578A (en) 1996-10-28
EP1443043A3 (de) 2005-02-02
PL311539A1 (en) 1996-06-10
PT716081E (pt) 2006-08-31
US5910593A (en) 1999-06-08
CN1216054C (zh) 2005-08-24
DE59511043D1 (de) 2006-05-18
TW310324B (zh) 1997-07-11

Similar Documents

Publication Publication Date Title
EP1036794A4 (en) 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
YU28500A (sh) Postupak za dobivanje 1,4-dihidropiridina i jedinjenja koja se primenjuju u tom postupku
IL116225A (en) Process and intermediates for the selective preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
DK0965588T3 (da) Fremgangsmåde til fremstilling af 4-phenyl-1,2,3,6-tetrahydropyridinderivater og mellemprodukter anvendt ved denne fremgangsmåde
WO2000018722A3 (es) Nuevos derivados de la 6-(4-fenilbutoxi)hexilamina y procedimiento para la obtencion de salmeterol
DK0665221T3 (da) Vitamin D derivat og fremgangsmåde til fremstilling af dette
ATE299489T1 (de) Aminderivate und verfahren zu ihrer herstellung
AU4029495A (en) Use of 1,2-bridged 1,4-dihydropyridines as medicaments
GR3022713T3 (en) Process for the vacylation of threonine derivatives and their use in the preparation of 1,4-dihydropyridines.
DE60018070D1 (de) Verfahren zur herstellung von morphine-6-glucuronide und derivate unter verwendung von haloglucuronatester
WO1998005640A3 (en) Process for the preparation of 3,3-disubstituted piperidines
NZ333769A (en) A process for preparing naphthyridones and azabicyclo(3.1.0)hexane intermediates for the compound trovafloxacin and derivatives thereof
DK0784603T3 (da) Racemisering af forstadier for levobupivacain og analoge forstadier heraf

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees